Scinai Immunotherapeutics Ltd (SCNI)
NASDAQ
Quarter End | 6 2022 | 9 2022 | 3 2023 | 6 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
総売上 | 0 | 11.2M | 0 | 0 | 9k | 124k | 284k | 168k |
営業利益 | -10.78M | 3.87M | -3.19M | -2.6M | -1.82M | -1.93M | -1.9M | -2.42M |
税引前収入 | -12.85M | 3.75M | -3.52M | -3.76M | -2.33M | -2.16M | -2.32M | 11.51M |
純利益 | -12.85M | 3.75M | -3.52M | -3.76M | -2.33M | -2.16M | -2.32M | 11.51M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -10.78M | 3.87M | -3.19M | -2.6M | -1.82M | -1.93M | -1.9M | -2.39M |
EBITDA | -10.78M | 3.87M | -3.05M | -2.6M | -1.74M | -1.77M | -1.41M | -1.92M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 12.68M | 40k | 0 | 9k |
営業利益 | -11.9M | -23.66M | -76.93M | -78.35M | -55.47M | -34.83M | -11.06M | -9.71M |
税引前収入 | -9.18M | -34.55M | -87.54M | -109.19M | -4.46M | -39.98M | -5.8M | -6.5M |
純利益 | -9.18M | -34.55M | -87.54M | -109.19M | -4.46M | -39.98M | -5.8M | -6.5M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.068 | -0.132 | -0.335 | -0.271 | -0.01 | -0.054 | -0.006 | -0.003 |
EBIT | -11.9M | -23.66M | -81.27M | -78.35M | -55.47M | -34.83M | -11.06M | -9.71M |
EBITDA | -11.28M | -23.22M | -76.67M | -76.71M | -53.96M | -33.31M | -10.5M | -9.19M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約